Abstract:Background & aims: Angiopoietin-like protein 8 (ANGPTL8) isa 198 amino-acid long, novel secreted protein that is mainly expressed in the liver and brown adipose tissues. At present, evidence supporting the involvement of ANGPTL8 in the regulation of glucose metabolism is inconclusive, along with its function in the liver. Previous studies mainly focused on the effect of ANGPTL8 on glucose metabolism in non-diabetic mice, and few relevant studies in diabetic mice exist. Therefore, this study aimed to investigate the role of ANGPTL8 on glucose homeo-stasis and elucidate the underlying mechanisms in diabetic mice. Methods: db/db diabetic and high-fat diet/streptozotocin-induced diabetic mice were injected with adenovirus expressing ANGPTL8 through the tail vein. Blood glucose levels were measured and glucose, insulin, and pyruvate tolerance tests were performed. To explore the molecular mechanism by which ANGPTL8 regulates hepatic glu-cose metabolism and manipulate mouse ANGPTL8 expression levels both in vivo and in vitro based on adenoviral transduction, gain-and loss-of-function strategies were adopted. Results: Adenovirus-mediated overexpression of ANGPTL8 decreased fasting blood glucose levels and improved glucose tolerance and insulin sensitivity in db/db and high-fat diet/streptozotocin-induced diabetic mice. ANGPTL8 knockdown yielded the opposite effects. ANGPTL8 was upregulated in the cAMP/Dex-induced hepato-cyte gluconeogenesis model. Moreover, ANGPTL8 overexpression in primary hepatocytes and diabetic mouse livers inhibited the expression of gluconeogenesis-related genes, including PEPCK and G6PC, by activating the AKT signaling pathway and, thereby, reducing glucose production. Therefore, the results demonstrated that ANGPTL8 improved glucose metabolism via inhibition of hepatic gluconeogenesis in diabetic mice. Conclusions: Current findings highlight a critical role of hepatic ANGPTL8 in glucose homeostasis, suggesting that increased ANGPTL8 expression could be an underlying factor for the inhibition of hepatic gluconeogenesis, which could be targeted for the prevention and treatment of type 2 diabetes. (c) 2021 Elsevier Inc. All rights reserved.

Involvement of KLF11 in Hepatic Glucose Metabolism in Mice Via Suppressing of PEPCK-C Expression.

Mouse KLF11 Regulates Hepatic Lipid Metabolism

KLF10 transcription factor regulates hepatic glucose metabolism in mice

The KLF14 Transcription Factor Regulates Hepatic Gluconeogenesis in Mice

Regulation Of Glucose Homeostasis And Lipid Metabolism By Ppp1r3g-Mediated Hepatic Glycogenesis

KCNH6 Enhanced Hepatic Glucose Metabolism through Mitochondrial Ca2+ Regulation and Oxidative Stress Inhibition

Hepatic ZBTB22 promotes hyperglycemia and insulin resistance via PEPCK1‐driven gluconeogenesis

The tumor suppressor gene lkb1 is essential for glucose homeostasis during zebrafish early development

Hepatic Krüppel-like factor 16 (KLF16) targets PPARα to improve steatohepatitis and insulin resistance

Involvement of Inducible 6-Phosphofructo-2-kinase in the Anti-diabetic Effect of Peroxisome Proliferator-activated Receptor Γ Activation in Mice

Roles of hepatic glucokinase in intertissue metabolic communication: Examination of novel liver-specific glucokinase knockout mice.

Hepatic Insulin Resistance and Increased Hepatic Glucose Production in Mice Lacking Fgf21.

Human Kruppel-Like Factor 11 (klf11) and Caccc Box Mutation Inhibit Activity of the Human Proinsulin Promoterin Pancreatic Beta-Cells

Control of hepatic gluconeogenesis by the promyelocytic leukemia zinc finger protein.

Characterization of the Gene Expression Profile of Heterozygous Liver-Specific Glucokinase Knockout Mice at A Young Age

Establishment of Liver Specific Glucokinase Gene Knockout Mice: a New Animal Model for Screening Anti-Diabetic Drugs.

Regulation of hepatic gluconeogenesis by nuclear factor Y transcription factor in mice

Liver-specific deletion of Ppp2c alpha enhances glucose metabolism and insulin sensitivity

Liver-specific deletion of Ppp2cα enhances glucose metabolism and insulin sensitivity.

Dexamethasone-induced Krüppel-like Factor 9 Expression Promotes Hepatic Gluconeogenesis and Hyperglycemia.

Angiopoietin-like Protein 8 (betatrophin) Inhibits Hepatic Gluconeogenesis Through PI3K/Akt Signaling Pathway in Diabetic Mice